NCT05498220 2026-04-16
Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma
UNC Lineberger Comprehensive Cancer Center
Phase 2 Terminated
UNC Lineberger Comprehensive Cancer Center
Cantonal Hospital of St. Gallen
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH
Rigshospitalet, Denmark
Assistance Publique - Hôpitaux de Paris